Login / Signup

Validation of a Decision Support System for Blueberry Anthracnose and Fungicide Sensitivity of Colletotrichum gloeosporioides Isolates.

Andre Bueno GamaLeandro G CordovaCarolina S RebelloNatalia A Peres
Published in: Plant disease (2021)
Blueberry is an increasingly important crop in Florida. Anthracnose fruit rot (AFR), caused mostly by Colletotrichum gloeosporioides, is favored by long wetness periods and temperatures from 15 to 27°C. Currently, the model in the Strawberry Advisory System (StAS) guides fungicide applications targeting strawberry AFR. Given the similarity between blueberry and strawberry AFR, we hypothesized that the model used in StAS could be used in a decision support system (DSS) built for blueberry AFR. There is no information on inhibition posed by fungicides on C. gloeosporioides isolates from blueberry. Our objectives were to demonstrate that the model used in the StAS could be used for blueberry AFR management in Florida and to assess the sensitivity of isolates to fungicides. Four trials were undertaken in blueberry fields in Florida during two seasons to compare the effectiveness of fungicide applications according to the model with that of the growers' standard calendar. Sensitivity of blueberry C. gloeosporioides isolates to azoxystrobin, benzovindiflupyr, penthiopyrad, pydiflumetofen, boscalid, thiophanate-methyl, fluazinam, and fludioxonil was evaluated. AFR incidence and yield were compared between treatments. Following recommendations from the model resulted in disease control as effective as the standard program and in some cases with fewer applications. All isolates were sensitive to benzovindiflupyr, penthiopyrad, fluazinam, and fludioxonil. Low frequency of in vitro inhibition of isolates by azoxystrobin, pydiflumetofen, boscalid, and thiophanate-methyl should raise concern about fungicide resistance. Our results indicate that the model used in StAS could be used in a DSS to help Florida growers to manage AFR in blueberry.
Keyphrases
  • randomized controlled trial
  • systematic review
  • healthcare
  • risk factors
  • drug delivery
  • climate change
  • social media
  • quality improvement